Inovio Pharmaceuticals, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| GBM.F | GNLX | IVVD | PDSB | HBP.TO | TVGN | |
|---|---|---|---|---|---|---|
| Market cap | 145.48M | 88.68M | 186.76M | 136.51M | 70.27M | 95.87M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | — | -2.6 | -1.2 | -6.8 | -8.4 | — |
| Price/book | 29.8 | 5.4 | 1.0 | -20.3 | 4.8 | -1.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −24.51% | −75.51% | −58.83% | +46.23% | −54.68% | −77.45% |
| Today | −4.42% | +2.08% | +8.96% | −7.80% | 0.00% | −3.38% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All GBM.F news ›Inovio Pharmaceuticals, Inc. (INO) Discusses FDA Accelerated Approval and Commercial Launch of VOCERYQ for RRP Transcript
Inovio Pharmaceuticals, Inc. (INO) Discusses FDA Accelerated Approval and Commercial Launch of VOCERYQ for RRP November 2, 2026 8:00 AM EST Jennie Willson - Director of CommunicationsJacqueline Shea - CEO, President & DirectorMichael…
Inovio Pharmaceuticals Stock Soars Nearly 193% in Trading
Shares of Inovio Pharmaceuticals surged nearly 193% in a sharp move that put the biotech stock at the top of trending lists. The rally drew heavy trading interest from investors looking to catch the momentum. Moomoo's daily roundup…
Inovio Pharmaceuticals stock jumps 190.83% as hourly RSI reaches 82.54
Inovio Pharmaceuticals stock carries a bullish daily bias, yet its trend structure is not fully aligned… Inovio Pharmaceuticals stock carries a bullish daily bias, yet its trend structure is not fully aligned. Price stands above all three…
Inovio Pharmaceuticals (NASDAQ:INO) Upgraded to Buy at HC Wainwright
Posted by Danessa Lincoln on Nov 2nd, 2026 Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) was upgraded by equities researchers at HC Wainwright from a “neutral” rating to a “buy” rating in a research report issued to clients and…
Critical Contrast: Inovio Pharmaceuticals (NASDAQ:INO) & Shattuck Labs (NASDAQ:STTK)
Posted by Tristan Rich on Nov 1st, 2026 Shattuck Labs (NASDAQ:STTK – Get Free Report) and Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will contrast…
Certain Common Stock of Inovio Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 28-OCT-2026.
These Common Stock will be under lockup for 91 days starting from 29-JUL-2026 to... Certain Common Stock of Inovio Pharmaceuticals, Inc are subject to a Lock-Up Agreement Ending on 28-OCT-
Transcript : Inovio Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 12, 2026
Presentation Operator MessageOperator Good afternoon, ladies and gentlemen, and welcome to the Inovio Second Quarter 2026 Financial Results Conference Call. [Operator Instructions] This call is Transcript : Inovio Pharmaceuticals, Inc., Q2…
Jefferies Upgrades Inovio Pharmaceuticals to Buy From Hold, Adjusts PT to $3 From $1.80
Inovio Pharmaceuticals has an average rating of overweight and mean price target of $7.50, according to analysts polled by FactSet. ... Biotechnology & Medical Research Jefferies Upgrades Inovio Pharmaceuticals to Buy From Hold, Adjusts PT…
Inovio Pharmaceuticals, Inc.: Relative Strength Chart - Stock Nasdaq
Compare Inovio Pharmaceuticals, Inc. with the company of your choice via a Relative Strength chart. Real-time INO price, Nasdaq stock exchange Relative Strength Chart Inovio Pharmaceuticals, Inc. Biotechnology & Medical Research All…
Inovio Pharmaceuticals Gets FDA Accelerated Approval for VOCERYQ
Inovio Pharmaceuticals said Friday the US Food and Drug Administration granted accelerated approval to VOCERYQ, a DNA-based immunotherapy indicated to reduce the frequency of surgical papilloma... Biotechnology & Medical Research Inovio…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com7
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.